129 related articles for article (PubMed ID: 19109979)
1. A continuum receptor model of hepatic lipoprotein metabolism.
Tindall MJ; Wattis JA; O'Malley BJ; Pickersgill L; Jackson KG
J Theor Biol; 2009 Apr; 257(3):371-84. PubMed ID: 19109979
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes.
Pearson T; Wattis JA; O'Malley B; Pickersgill L; Blackburn H; Jackson KG; Byrne HM
J Math Biol; 2009 Jun; 58(6):845-80. PubMed ID: 18704423
[TBL] [Abstract][Full Text] [Related]
3. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
5. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
Koo C; Wernette-Hammond ME; Garcia Z; Malloy MJ; Uauy R; East C; Bilheimer DW; Mahley RW; Innerarity TL
J Clin Invest; 1988 May; 81(5):1332-40. PubMed ID: 3163347
[TBL] [Abstract][Full Text] [Related]
6. Comparative reactivity of remnant-like lipoprotein particles (RLP) and low-density lipoprotein (LDL) to LDL receptor and VLDL receptor: effect of a high-dose statin on VLDL receptor expression.
Imagawa M; Takahashi S; Zenimaru Y; Kimura T; Suzuki J; Miyamori I; Iwasaki T; Hattori H; Yamamoto TT; Nakano T; Nakajima K
Clin Chim Acta; 2012 Feb; 413(3-4):441-7. PubMed ID: 22085424
[TBL] [Abstract][Full Text] [Related]
7. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein receptors.
Lestavel S; Fruchart JC
Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):461-81. PubMed ID: 8061563
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
12. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N; Wolfbauer G
Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
[TBL] [Abstract][Full Text] [Related]
13. Lipid transport in the developing bovine follicle: messenger RNA expression increases for selective uptake receptors and decreases for endocytosis receptors.
Argov N; Moallem U; Sklan D
Biol Reprod; 2004 Aug; 71(2):479-85. PubMed ID: 15056566
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cholesterol homeostasis: is the low-density lipoprotein pathway a regulatory or a shunt pathway?
Sniderman AD; Qi Y; Ma CI; Wang RH; Naples M; Baker C; Zhang J; Adeli K; Kiss RS
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2481-90. PubMed ID: 23990208
[TBL] [Abstract][Full Text] [Related]
15. VLDL and LDL metabolism in human and rat mesangial cells.
Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Wieland H; Schollmeyer P; Wanner C
Nephron; 1996; 74(2):378-85. PubMed ID: 8893159
[TBL] [Abstract][Full Text] [Related]
16. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
Kamps JA; van Berkel TJ
Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.
Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
Am J Physiol; 1999 Mar; 276(3):E553-7. PubMed ID: 10070023
[TBL] [Abstract][Full Text] [Related]
18. Membrane binding sites for plasma lipoproteins on endosomes from rat liver.
Jaeckle S; Brady SE; Havel RJ
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1880-4. PubMed ID: 2538819
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells.
Pussinen PJ; Lindner H; Glatter O; Reicher H; Kostner GM; Wintersperger A; Malle E; Sattler W
Biochim Biophys Acta; 2000 May; 1485(2-3):129-44. PubMed ID: 10832094
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro.
Chappell DA; Fry GL; Waknitz MA; Muhonen LE; Pladet MW
J Biol Chem; 1993 Dec; 268(34):25487-93. PubMed ID: 8244984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
